Your paediatrician is not being contrarian, and the programme is not being reckless. This is one of the few parenting questions where two careful people read the same evidence and land in different places. We cannot settle it for you โ but we can show you what each side is standing on.
The nine-month dose is a population measure, built around how much deficiency exists across a whole population. Your paediatrician is making an individual judgement about one well-fed child in front of her. Those are different questions, and conflating them is the commonest mistake made about this.
Not medical advice โ consult your pediatrician about your baby's specific health needs.
What the programme actually is
India's National Health Mission states that under this programme "prophylactic dosages are administered to all children aged 9 months to 5 years," nine doses in all, the nine-month one listed as 100,000 IU โ one lakh โ and later ones as 200,000 IU. It is timed to the measles-containing vaccine visit, which is why it surfaces at the same appointment as the shot itself.
Note the word prophylactic. A 2022 perspective in the European Journal of Clinical Nutrition by an ICMR-National Institute of Nutrition scientist records that India launched this in 1970 as a "National program for prophylaxis against blindness in children due to vitamin A deficiency" โ built to stop children going blind when that was happening at scale.
The global rule it follows is explicitly conditional. WHO's evidence library states that high-dose supplementation is recommended "in settings where vitamin A deficiency is a public health problem" โ defined by population thresholds, such as low serum retinol in 20% or more of children aged 6โ59 months. And WHO's 2011 guideline page describes the document as intended "for policy-makers, their expert advisers, and technical and programme staff." It is advice to governments about populations, not a prescription for your daughter.
Why the evidence genuinely moved
For decades the case looked straightforward: supplementation cut child deaths substantially. Then came DEVTA. This cluster-randomised trial of about a million pre-school children in Uttar Pradesh reported a mortality ratio of 0.96 (95% CI 0.89โ1.03, p=0.22) โ no significant effect โ and its authors wrote that it "contradicts the expectation from other trials that vitamin A supplementation would reduce child mortality by 20-30%, but cannot rule out some more modest effect." It was funded by the UK Medical Research Council, USAID and the World Bank, with the vitamin A donated by Roche.
Now the part that complicates the story in the other direction. Pooling DEVTA with the earlier trials, the 2022 Cochrane review found a 12% reduction in all-cause mortality across 19 trials and 1,202,382 children (RR 0.88, 95% CI 0.83 to 0.93), rated high-certainty, even while its own summary acknowledges that "one large, recently conducted study, which included about one million children, did not show any effect." The benefit did not vanish โ it shrank, and the reviewers kept their confidence in it. Worth knowing, though: that update's search "identified no new RCTs", so the evidence base is largely old trials from far more deficient populations.
What shifted decisively is the Indian picture. The Comprehensive National Nutrition Survey reported 18% of children aged 1โ4 deficient, reaching the severe-public-health-problem threshold in 12 states. An ICMR-NIN analysis of the same survey put the national figure at 15.7% after adjusting for inflammation, with only three states significantly above 20%. Either way, India as a whole now sits near or below the line WHO set for running the programme at all.
So: the global evidence still points to a modest benefit; the Indian case for giving it to every child is weaker than it was.
What Indian paediatricians have said
This is why your doctor's position is a mainstream one. Writing as President of the Indian Academy of Pediatrics in April 2021, Piyush Gupta argued that "except these seven states, the universal MDVAS can be safely discontinued in other areas," citing "improved diets, substantial declines in under-five mortality, and lack of consistent evidence of survival benefit in the Indian context." Earlier, the IAP's nutrition chapter, in a position the Academy endorsed as official policy, stated that "recent data indicates that Vitamin A supplementation in infancy does not have any beneficial effect on growth, morbidity, and mortality."
It is not settled even among Indian nutrition scientists: the ICMR-NIN author who documented the programme's history argues that moving from universal to geographically targeted supplementation would be detrimental, because deficiency does not stop at a state border.
"A balanced diet is enough" โ what is true, and what is not
Partly true, with a catch. MedlinePlus notes that vitamin A comes both from animal foods โ eggs, dairy, fish โ and from "orange and yellow vegetables and fruits, such as carrots, sweet potatoes, mangos" and "most dark green, leafy vegetables," absorbed better "with a small amount of fat." Ghee on the dal is doing something.
The catch is conversion. A review in the American Journal of Clinical Nutrition states that "the bioconversion of traditional dietary sources of ฮฒ-carotene to vitamin A is much less efficient than previously supposed." A largely vegetarian plate is not worthless, but it is a weaker route than retinol from eggs, dairy or fish.
There is also a ceiling. The ICMR-NIN analysis estimated dietary inadequacy at around 70%, falling to 25% once fortified oil and milk are counted โ and that adding the programme dose on top raised the chance of exceeding the tolerable upper intake limit to 30% in one- to three-year-olds, children being more sensitive to excess vitamin A than adults. That is probably the strongest card your paediatrician holds. (Stacking is a recurring theme โ see vitamin D, iron drops and what else is in the bottle.)
What would move a particular child up or down the risk scale
| Points towards more concern | Points towards less |
|---|---|
| One of the 12 states where CNNS found deficiency at severe-public-health levels | A state where the same survey found low prevalence |
| Low intake at home โ CNNS found deficiency twice as high in the poorest wealth quintile as in the richest | Eggs, dairy, greens and fortified oil in the diet, which ICMR-NIN modelling shows cuts inadequacy sharply |
| The conditions IAP's parental guidelines name โ severe undernutrition, measles, long-standing diarrhoea or absorption problems, liver disease, eye complaints. WHO separately recommends vitamin A for suspected measles, at doses the practitioner sets | None of those, and normal growth |
Urban residence is not on that list: CNNS found no urbanโrural difference, so city children are not automatically fine. IAP's parent guidance is careful too: a balanced diet "logically" supplies what a child needs, "but this may not always be so."
Three questions worth asking her
- Is your view about children in general, or about mine specifically โ and what did you see in her that made you say it?
- Does our state fall inside or outside the high-prevalence group, and does that change your answer?
- If we skip it, what would you want to watch for, and when would you revisit it?
Each gives her room to be specific. If her reasoning still doesn't land, handling a clinician's claim you can't verify is its own skill โ we walked through it here.
We will not tell you to override her, nor to defy the programme. She has examined your baby; we have read papers. This is a conversation for the two of you.
Frequently asked questions
Has WHO changed its recommendation? Not in substance. WHO's evidence library still carries the conditional recommendation for settings where deficiency is a public health problem, and the underlying guideline dates from 2011. What changed is India's own prevalence data.
Are there side effects? Cochrane reported an increased risk of vomiting within 48 hours of a dose (RR 1.97, 95% CI 1.44 to 2.69), rated moderate-certainty. Nothing in that review suggests lasting harm at programme doses.
